DK463989A - Farmaceutisk virksom kombination - Google Patents

Farmaceutisk virksom kombination Download PDF

Info

Publication number
DK463989A
DK463989A DK463989A DK463989A DK463989A DK 463989 A DK463989 A DK 463989A DK 463989 A DK463989 A DK 463989A DK 463989 A DK463989 A DK 463989A DK 463989 A DK463989 A DK 463989A
Authority
DK
Denmark
Prior art keywords
pharmaceutical active
active combination
thrombosis
component
pharmaceutical composition
Prior art date
Application number
DK463989A
Other languages
Danish (da)
English (en)
Other versions
DK463989D0 (da
Inventor
Jutta Heim
Giancarlo Agnelli
Czeslaw Czendlik
Original Assignee
Ciba Geigy Ag
Ucp Gen Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10643975&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK463989(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ciba Geigy Ag, Ucp Gen Pharma Ag filed Critical Ciba Geigy Ag
Publication of DK463989D0 publication Critical patent/DK463989D0/da
Publication of DK463989A publication Critical patent/DK463989A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
DK463989A 1988-09-21 1989-09-20 Farmaceutisk virksom kombination DK463989A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888822147A GB8822147D0 (en) 1988-09-21 1988-09-21 Pharmaceutically active combination

Publications (2)

Publication Number Publication Date
DK463989D0 DK463989D0 (da) 1989-09-20
DK463989A true DK463989A (da) 1990-03-22

Family

ID=10643975

Family Applications (1)

Application Number Title Priority Date Filing Date
DK463989A DK463989A (da) 1988-09-21 1989-09-20 Farmaceutisk virksom kombination

Country Status (15)

Country Link
US (1) US5126134A (de)
EP (1) EP0365468B1 (de)
JP (1) JPH02121934A (de)
KR (1) KR0149001B1 (de)
AT (1) ATE101524T1 (de)
AU (1) AU628854B2 (de)
CA (1) CA1336493C (de)
DE (1) DE68913132T2 (de)
DK (1) DK463989A (de)
GB (1) GB8822147D0 (de)
IE (1) IE62434B1 (de)
IL (1) IL91706A (de)
NZ (1) NZ230691A (de)
PH (1) PH27420A (de)
ZA (1) ZA897173B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8927722D0 (en) * 1989-12-07 1990-02-07 British Bio Technology Proteins and nucleic acids
US5837808A (en) * 1991-08-20 1998-11-17 Baxter International Inc. Analogs of hirudin
WO1993014199A1 (en) * 1992-01-13 1993-07-22 Abbott Laboratories A pump-1 catalyzed method of making low molecular weight urokinase-type plasminogen activator
ZA936478B (en) * 1992-09-03 1994-09-30 Regeneron Pharma Dorsal tissue affecting factor and compositions
EP0625580A4 (en) * 1992-09-28 1994-12-21 Japan Energy Corporation Novel hirudine variant, process for producing the same, and anticoagulant containing the same as active ingredient.
DE4323754C1 (de) * 1993-07-15 1994-12-01 Gruenenthal Gmbh Bifunktionelle Urokinasevarianten mit verbesserten fibrinolytischen Eigenschaften und thrombinhemmender Wirkung
US5972648A (en) * 1993-09-28 1999-10-26 Japan Energy Corporation Hirudin analogs, methods of manufacture thereof and anticoagulant compositions having these as active ingredients
US5510330A (en) * 1994-03-25 1996-04-23 Boehringer Mannheim Gmbh Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof.
US5759542A (en) * 1994-08-05 1998-06-02 New England Deaconess Hospital Corporation Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular and other diseases
DE4440892A1 (de) * 1994-11-17 1996-05-23 Gruenenthal Gmbh Proteine mit fibrinolytischen und gerinnungshemmenden Eigenschaften
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
GB2394498B (en) * 2002-10-23 2006-08-09 Engineering Business Ltd Mounting of offshore structures
GB0306547D0 (en) * 2003-03-21 2003-04-23 Engineering Business Ltd Apparatus for creating a local reduction in wave height
US20050036984A1 (en) * 2003-06-17 2005-02-17 Harrison Roger G. Conjugate for the specific targeting of anticancer agents to cancer cells and production thereof
US20110002978A1 (en) 2003-06-17 2011-01-06 Harrison Roger G Enzyme prodrug cancer therapy selectively targeted to tumor cells or tumor vasculature and methods of production and use thereof
US7976847B2 (en) * 2004-01-13 2011-07-12 Vasogenix Pharmaceuticals, Inc. Controlled release CGRP delivery composition for cardiovascular and renal indications
WO2005070445A2 (en) * 2004-01-13 2005-08-04 Vasogenix Pharmaceuticals, Inc. Methods for treating acute myocardial infarction by calcitonin gene related peptide and compositions containing the same
CA2552757A1 (en) * 2004-01-13 2005-08-04 Vasogenix Pharmaceuticals, Inc. Methods of using cgrp for cardiovascular and renal indications
ATE414010T1 (de) * 2004-08-03 2008-11-15 Ihc Engineering Business Ltd Zugangsverfahren zwischen schiffskonstruktionen und gerät
GB0503083D0 (en) * 2005-02-15 2005-03-23 Engineering Business Ltd Launch and recovery apparatus and method
UA95903C2 (ru) 2005-02-24 2011-09-26 Дифьюжен Фармасьютикалз Ллк Транс-каротиноиды, их синтез, лекарственная форма и применение
GB2428656B (en) 2005-08-01 2009-08-05 Engineering Business Ltd Gangway apparatus
GB2434823A (en) * 2006-02-06 2007-08-08 Engineering Business Ltd Transport and installation of offshore structures
JP2010524855A (ja) 2007-04-13 2010-07-22 ディフュージョン・ファーマシューティカルズ・エルエルシー 末梢血管疾患の前処置としての、及びその処置における双極性トランスカロテノイドの使用
US20090214469A1 (en) * 2008-02-25 2009-08-27 Jeffrey Gold Methods and Compositions for the Treatment of Sepsis
CN108464976A (zh) 2009-06-22 2018-08-31 扩散药品有限公司 扩散促进化合物及其单独或与溶栓药一起的应用
EP2575487B1 (de) 2010-06-02 2017-10-18 Diffusion Pharmaceuticals Llc Orale formulierungen aus bipolaren transkarotinoiden
US9987241B2 (en) 2014-09-25 2018-06-05 The Board Of Regents Of The University Of Oklahoma Enzyme conjugate and prodrug cancer therapy
CN115089569A (zh) 2016-03-24 2022-09-23 扩散药品有限公司 双极性反式类胡萝卜素连同化疗和放射治疗在治疗癌症中的用途
US11446365B2 (en) 2017-08-09 2022-09-20 The Board Of Regents Of The University Of Oklahoma Antimalarial enzyme conjugates, kits containing same, and methods of producing and using same
US11613744B2 (en) 2018-12-28 2023-03-28 Vertex Pharmaceuticals Incorporated Modified urokinase-type plasminogen activator polypeptides and methods of use
MX2021007843A (es) 2018-12-28 2021-08-11 Vertex Pharma Polipeptidos de activador de plasminogeno, tipo urocinasa, modificados y metodos de uso.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8003402A (nl) * 1980-06-11 1982-01-04 Leuven Res & Dev Vzw Nieuwe plasminogeen-activator en farmaceutisch preparaat met trombolytische werking.
DE3342139A1 (de) * 1983-11-22 1985-05-30 Ciba-Geigy Ag, Basel Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel
JPS61112018A (ja) * 1984-11-06 1986-05-30 Mitsubishi Chem Ind Ltd 線溶増強剤
DE3544318A1 (de) * 1985-12-14 1987-06-19 Behringwerke Ag Mittel aus einem plasmin-inhibitor und einem plasminogen-aktivator zur behandlung von thrombosen
JP2739050B2 (ja) * 1988-01-28 1998-04-08 ヘキスト薬品工業株式会社 抗血液凝固剤
DE3804600A1 (de) * 1988-02-13 1989-08-24 Basf Ag Mischung aus einer thrombolytisch wirkenden und einer antithrombotischen substanz

Also Published As

Publication number Publication date
US5126134A (en) 1992-06-30
ZA897173B (en) 1990-09-26
AU628854B2 (en) 1992-09-24
IL91706A0 (en) 1990-06-10
IL91706A (en) 1997-07-13
CA1336493C (en) 1995-08-01
EP0365468A1 (de) 1990-04-25
EP0365468B1 (de) 1994-02-16
IE893015L (en) 1990-03-21
IE62434B1 (en) 1995-02-08
ATE101524T1 (de) 1994-03-15
DK463989D0 (da) 1989-09-20
AU4135289A (en) 1990-03-29
DE68913132T2 (de) 1994-07-07
DE68913132D1 (de) 1994-03-24
PH27420A (en) 1993-06-21
KR900004349A (ko) 1990-04-12
GB8822147D0 (en) 1988-10-26
KR0149001B1 (ko) 1998-10-15
JPH02121934A (ja) 1990-05-09
NZ230691A (en) 1992-03-26

Similar Documents

Publication Publication Date Title
DK463989A (da) Farmaceutisk virksom kombination
GR3020036T3 (en) Inhibition of arterial thrombotic occlusion or thromboembolism
NO172389C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazoler
ATE104151T1 (de) Trombosebehandlung mit fibrinolytika und prostacyclinen.
NO178546C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive ACE-hemmere med nootrop virkning
DK254588D0 (da) Antibiotika
ES2061842T3 (es) Utilizacion del inhibidor de activador de plasminogeno (pai-2) para la inmunosupresion.
DK305490D0 (da) Vaevsplasminogenaktivator-analoger med forbedret aktivitet
NO921223D0 (no) Kombinasjonspreparat med antitrombotisk virkning
NO306537B1 (no) Anvendelse av en inhibitor for fremstilling av et medikament
ES2094757T3 (es) Un factor megacariocitopoyetico.
PT83721B (pt) Processo de preparacao de composicoes farmaceuticas a base de activadores de plasminogenio com actividade trombolitica
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
ATE94407T1 (de) Pharmazeutische zusammensetzungen.
ES2033096T3 (es) Medicamentos que contienen activador de plasminogeno de tejidos.
NO890261D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.
AU612562B2 (en) A composition comprising a plasmin inhibitor and a plasminogen activator for the treatment of thrombosis

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment